Assessing the Japet.W+ Lumbar Traction Device in Rehabilitation for Patients With Non-specific Mechanical Low Back Pain

NCT ID: NCT06718348

Last Updated: 2025-08-20

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-11-20

Study Completion Date

2025-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The study will include patients suffering from nonspecific mechanical low back pain for more than 6 weeks. Two groups will be compared. A Control group and an Experimental group with the exoskeleton JAPET.W

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The study will include patients suffering from nonspecific mechanical low back pain for more than 6 weeks. The study will consist of two groups: a control group (Group CTRL) and an experimental group (Group EXP). Participants will be categorized into two categories: "workers," patients on temporary work leave due to low back pain, and "non-workers," patients unable to work due to this condition after exhausting all available therapeutic solutions.

Monitoring period (30 physiotherapy sessions): evaluations will be conducted at sessions 1, 15 and 30, on the two groups. Evaluation session 3 months after the end of the physiotherapy sessions.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Low Back Pain, Mechanical

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group CTRL

Participants will undergo 30 sessions of conventional physiotherapy

Group Type NO_INTERVENTION

No interventions assigned to this group

Group EXP

Participants will undergo 30 sessions of physiotherapy with the use of the Japet.W+ Exoskeleton

Group Type EXPERIMENTAL

Use of the Exoskeleton JAPET.W

Intervention Type OTHER

Phsysiotherapy sessions with the support of the Exoskeleton JAPET.W

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Use of the Exoskeleton JAPET.W

Phsysiotherapy sessions with the support of the Exoskeleton JAPET.W

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Nonspecific mechanical low back pain for more than 6 weeks,
* 18 years ≤ Age \< 80 years,
* Patient affiliated to the health social security system,
* Patient able to understand the information relating to the study and to sign the informed consent form

Exclusion Criteria

* Specific low back pain (infectious, inflammatory, tumorous, or traumatic origin),
* Motor neurological deficits (peripheral or central),
* Extrapyramidal syndrome,
* Treatment with implanted neurostimulation,
* Cardiac or circulatory diseases or serious respiratory problems,
* Previous recent arthrodesis or recent lumbar prosthesis surgery,
* Surgery for herniated disc (\<3 months),
* Fracture of the dorsolumbar spine or rib (\<3 months),
* Skin lesions, contusions and stretching injuries of the trunk,
* Pregnancy,
* Individuals not tolerating the JAPET.W+ device during an initial trial,
* Under guardianship, curatorship or legal protection
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Grand Hôpital de Charleroi

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Serge TROUSSEL, MD

Role: PRINCIPAL_INVESTIGATOR

Grand Hôpital de Charleroi

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Grand Hôpital de Charleroi

Charleroi, Hainaut, Belgium

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Belgium

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Serge TROUSSEL, MD

Role: CONTACT

0032 71 10 ext. 3638

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Serge TROUSSEL, MD

Role: primary

Aline Gillain, MSc

Role: backup

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

EXO-Exoskeleton Japet.W

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Spinal Kinematics Variability
NCT03507296 COMPLETED
Weight Reduction in CLBP
NCT04824248 RECRUITING NA